Merck's new antiviral molnupiravir (Quality Stock Arts / Shutterstock)
As Omicron spread looms, oral antivirals appear to be one of the best defenses — now we just need more
After South African scientists reported a new Covid-19 variant — dubbed Omicron by the WHO — scientists became concerned about how effective vaccines and monoclonal antibodies might …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
